Pulmonary hypertension and pregnancy

被引:63
作者
Madden, B. P. [1 ]
机构
[1] St George Hosp, Dept Cardiothorac Med, Tooting London SW16 0QT, England
关键词
Pregnancy; Pulmonary hypertension; Plexogenic pulmonary arteriopathy; Pulmonary vasoactive compounds; INHALED NITRIC-OXIDE; EISENMENGER-SYNDROME; VASCULAR-DISEASE; PARENCHYMAL LUNG; COR-PULMONALE; BLOOD-VOLUME; SILDENAFIL; MANAGEMENT; DELIVERY; THERAPY;
D O I
10.1016/j.ijoa.2008.10.006
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Pulmonary hypertension is defined by a mean pulmonary artery pressure of greater than 25 mmHg at rest or 30 mmHg with exercise. It can occur in association with a variety of medical conditions. The most serious elevation in pulmonary artery pressures are seen in a group of conditions that share the histological entity of plexogenic Pulmonary arteriopathy. Pulmonary hypertension may be missed or diagnosed late in the course of the illness. It is associated with a poor prognosis. Pulmonary hypertension carries a significant risk to mother and child during pregnancy and pregnant women with pulmonary hypertension require careful monitoring within the framework of a multidisciplinary team. Specific targeted therapy for pulmonary hypertension may be required during pregnancy. Many agents are contraindicated because of risks of teratogenicity or secretion into breast milk. The optimum mode of delivery is not clear but early input from the high-risk obstetric anaesthesia team is essential. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:156 / 164
页数:9
相关论文
共 48 条
  • [1] *ACOG, 2002, OBSTET GYNECOL, V100, P845
  • [2] The nineteenth pregnancy in a patient with cor pulmonale and severe pulmonary hypertension: A management challenge
    Al-Mobeireek, AF
    Almutawa, J
    Alsatli, RA
    [J]. ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2003, 82 (07) : 676 - 678
  • [3] Sitaxsentan therapy for pulmonary arterial hypertension
    Barst, RJ
    Langleben, D
    Frost, A
    Horn, EM
    Oudiz, R
    Shapiro, S
    McLaughlin, V
    Hill, N
    Tapson, VF
    Robbins, IM
    Zwicke, D
    Duncan, B
    Dixon, RAF
    Frumkin, LR
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2004, 169 (04) : 441 - 447
  • [4] Use of antithrombotic agents during pregnancy
    Bates, SA
    Greer, IA
    Hirsh, J
    Ginsberg, JS
    [J]. CHEST, 2004, 126 (03) : 627S - 644S
  • [5] Endothelin antagonists
    Benigni, A
    Remuzzi, G
    [J]. LANCET, 1999, 353 (9147) : 133 - 138
  • [6] CARDIOVASCULAR CHANGES IN EARLY PHASE OF PREGNANCY
    CAPELESS, EL
    CLAPP, JF
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1989, 161 (06) : 1449 - 1453
  • [7] Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study
    Channick, RN
    Simonneau, G
    Sitbon, O
    Robbins, IM
    Frost, A
    Tapson, VF
    Badesch, DB
    Roux, S
    Rainisio, M
    Bodin, F
    Rubin, LJ
    [J]. LANCET, 2001, 358 (9288) : 1119 - 1123
  • [8] Cardiovascular function before, during, and after the first and subsequent pregnancies
    Clapp, JF
    Capeless, E
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1997, 80 (11) : 1469 - 1473
  • [9] Cell-autonomous and nonautonomous actions of endothelin-A receptor signaling in craniofacial and cardiovascular development
    Clouthier, DE
    Williams, SC
    Hammer, RE
    Richardson, JA
    Yanagisawa, M
    [J]. DEVELOPMENTAL BIOLOGY, 2003, 261 (02) : 506 - 519
  • [10] Eisenmenger syndrome - Factors relating to deterioration and death
    Daliento, L
    Somerville, J
    Presbitero, P
    Menti, L
    Brach-Prevert, S
    Rizzoli, G
    Stone, S
    [J]. EUROPEAN HEART JOURNAL, 1998, 19 (12) : 1845 - 1855